Purchases and Sales Made in Q4 2023 in Apellis Pharmaceuticals, Inc. (APLS)
This table provides information about the institutional ownership of Apellis Pharmaceuticals, Inc. (APLS) during Q4 2023. The information is specifically focused on institutions that hold shares of Apellis Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-323K- 9.97% |
$12M - $20.9M
|
2.92M
$96.6M
|
|
|
Feb 14, 2024
Q4 2023
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-338K- 26.84% |
$12.6M - $21.9M
|
922K
$30.6M
|
|
|
Feb 14, 2024
Q4 2023
|
Macquarie Group LTD
Australia, C3 |
SELL
|
- |
-493K- 45.81% |
$18.3M - $32M
|
583K
$19.3M
|
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-906K- 98.64% |
$33.7M - $58.7M
|
12.5K
$415K
|
|
|
Feb 14, 2024
Q4 2023
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-1.38M- 68.75% |
$51.1M - $89.1M
|
625K
$20.7M
|